John A. T. Young - Publications

Affiliations: 
2003- immunology and microbial pathogenesis program Salk Institute for Biological Studies, La Jolla, CA, United States 
Website:
http://www.salk.edu/insidesalk/articlenin.php?id=209

90 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Liu Y, Li Y, Bai YP, Fan XX. Association Between Physical Activity and Lower Risk of Lung Cancer: A Meta-Analysis of Cohort Studies. Frontiers in Oncology. 9: 5. PMID 30723700 DOI: 10.3389/fonc.2019.00005  0.4
2017 Yi F, Guo J, Dabbagh D, Spear M, He S, Kehn-Hall K, Fontenot J, Yin Y, Bibian M, Park CM, Zheng K, Park H, Soloveva V, Gharaibeh D, Retterer C, ... ... Young JA, et al. Discovery of Novel Small Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. Journal of Virology. PMID 28381571 DOI: 10.1128/JVI.02418-16  1
2016 Swann J, Murry J, Young JA. Cytosolic sulfotransferase 1A1 regulates HIV-1 minus-strand DNA elongation in primary human monocyte-derived macrophages. Virology Journal. 13: 30. PMID 26906565 DOI: 10.1186/s12985-016-0491-9  1
2015 Pache L, Dutra MS, Spivak AM, Marlett JM, Murry JP, Hwang Y, Maestre AM, Manganaro L, Vamos M, Teriete P, Martins LJ, König R, Simon V, Bosque A, Fernandez-Sesma A, ... ... Young JA, et al. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency. Cell Host & Microbe. 18: 345-53. PMID 26355217 DOI: 10.1016/j.chom.2015.08.009  1
2015 Miller MS, Rialdi A, Ho JS, Tilove M, Martinez-Gil L, Moshkina NP, Peralta Z, Noel J, Melegari C, Maestre AM, Mitsopoulos P, Madrenas J, Heinz S, Benner C, Young JA, et al. Senataxin suppresses the antiviral transcriptional response and controls viral biogenesis. Nature Immunology. 16: 485-94. PMID 25822250 DOI: 10.1038/ni.3132  1
2015 Liao HK, Gu Y, Diaz A, Marlett J, Takahashi Y, Li M, Suzuki K, Xu R, Hishida T, Chang CJ, Esteban CR, Young J, Izpisua Belmonte JC. Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells. Nature Communications. 6: 6413. PMID 25752527 DOI: 10.1038/ncomms7413  1
2014 Murry JP, Godoy J, Mukim A, Swann J, Bruce JW, Ahlquist P, Bosque A, Planelles V, Spina CA, Young JA. Sulfonation pathway inhibitors block reactivation of latent HIV-1. Virology. 471: 1-12. PMID 25310595 DOI: 10.1016/j.virol.2014.08.016  1
2014 Rodgers MJ, Banks DJ, Bradley KA, Young JA. CHD1 and CHD2 are positive regulators of HIV-1 gene expression. Virology Journal. 11: 180. PMID 25297984 DOI: 10.1186/1743-422X-11-180  1
2014 King HL, Keller SB, Giancola MA, Rodriguez DA, Chau JJ, Young JA, Little SJ, Smith DM. Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). Aids and Behavior. 18: 1722-5. PMID 25017425 DOI: 10.1007/s10461-014-0845-5  1
2014 Little SJ, Kosakovsky Pond SL, Anderson CM, Young JA, Wertheim JO, Mehta SR, May S, Smith DM. Using HIV networks to inform real time prevention interventions. Plos One. 9: e98443. PMID 24901437 DOI: 10.1371/journal.pone.0098443  1
2014 Emig-Agius D, Olivieri K, Pache L, Shih HL, Pustovalova O, Bessarabova M, Young JA, Chanda SK, Ideker T. An integrated map of HIV-human protein complexes that facilitate viral infection. Plos One. 9: e96687. PMID 24817247 DOI: 10.1371/journal.pone.0096687  1
2014 Manganaro L, Pache L, Herrmann T, Marlett J, Hwang Y, Murry J, Miorin L, Ting AT, König R, García-Sastre A, Bushman FD, Chanda SK, Young JA, Fernandez-Sesma A, Simon V. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner. Journal of Virology. 88: 7528-40. PMID 24760882 DOI: 10.1128/JVI.00239-14  1
2014 Ivetac A, Swift SE, Boyer PL, Diaz A, Naughton J, Young JA, Hughes SH, McCammon JA. Discovery of novel inhibitors of HIV-1 reverse transcriptase through virtual screening of experimental and theoretical ensembles. Chemical Biology & Drug Design. 83: 521-31. PMID 24405985 DOI: 10.1111/cbdd.12277  1
2013 Bruce JW, Reddington R, Mathieu E, Bracken M, Young JA, Ahlquist P. ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter. Plos Pathogens. 9: e1003712. PMID 24204263 DOI: 10.1371/journal.ppat.1003712  1
2013 Pérez-Santiago J, Gianella S, Massanella M, Spina CA, Karris MY, Var SR, Patel D, Jordan PS, Young JA, Little SJ, Richman DD, Smith DM. Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection. Aids (London, England). 27: 1921-31. PMID 24180001 DOI: 10.1097/QAD.0b013e3283611816  1
2013 Bhattacharyya S, Zagórska A, Lew ED, Shrestha B, Rothlin CV, Naughton J, Diamond MS, Lemke G, Young JA. Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors. Cell Host & Microbe. 14: 136-47. PMID 23954153 DOI: 10.1016/j.chom.2013.07.005  1
2013 Seidel S, Bruce J, Leblanc M, Lee KF, Fan H, Ahlquist P, Young JA. ZASC1 knockout mice exhibit an early bone marrow-specific defect in murine leukemia virus replication. Virology Journal. 10: 130. PMID 23617998 DOI: 10.1186/1743-422X-10-130  1
2013 Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. The New England Journal of Medicine. 368: 218-30. PMID 23323898 DOI: 10.1056/NEJMoa1110187  1
2013 Gianella S, Morris SR, Vargas MV, Young JA, Callahan B, Richman DD, Little SJ, Smith DM. Role of seminal shedding of herpesviruses in HIV Type 1 Transmission. The Journal of Infectious Diseases. 207: 257-61. PMID 23148284 DOI: 10.1093/infdis/jis683  1
2013 Gianella S, Morris SR, Anderson C, Spina CA, Vargas MV, Young JA, Richman DD, Little SJ, Smith DM. Herpes viruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract. Aids (London, England). 27: 39-47. PMID 22739399 DOI: 10.1097/QAD.0b013e3283573305  1
2012 Elleder D, Baiga TJ, Russell RL, Naughton JA, Hughes SH, Noel JP, Young JA. Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase. Virology Journal. 9: 305. PMID 23231773 DOI: 10.1186/1743-422X-9-305  1
2012 Gianella S, Mehta SR, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells. Virology. 434: 2-4. PMID 23040890 DOI: 10.1016/j.virol.2012.09.010  1
2012 Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen. Journal of Medical Virology. 84: 1703-9. PMID 22997072 DOI: 10.1002/jmv.23398  1
2012 Grönwall C, Kosakovsky Pond SL, Young JA, Silverman GJ. In vivo VL-targeted microbial superantigen induced global shifts in the B cell repertoire. Journal of Immunology (Baltimore, Md. : 1950). 189: 850-9. PMID 22696444 DOI: 10.4049/jimmunol.1200245  1
2012 Reeves CV, Wang X, Charles-Horvath PC, Vink JY, Borisenko VY, Young JA, Kitajewski JK. Anthrax toxin receptor 2 functions in ECM homeostasis of the murine reproductive tract and promotes MMP activity. Plos One. 7: e34862. PMID 22529944 DOI: 10.1371/journal.pone.0034862  1
2012 Thomas D, Naughton J, Cote C, Welkos S, Manchester M, Young JA. Delayed toxicity associated with soluble anthrax toxin receptor decoy-Ig fusion protein treatment. Plos One. 7: e34611. PMID 22511955 DOI: 10.1371/journal.pone.0034611  1
2012 Mehta SR, Kosakovsky Pond SL, Young JA, Richman D, Little S, Smith DM. Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California. The Journal of Infectious Diseases. 205: 1529-33. PMID 22448013 DOI: 10.1093/infdis/jis231  1
2012 Jäger S, Cimermancic P, Gulbahce N, Johnson JR, McGovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, Hernandez H, Jang GM, Roth SL, Akiva E, Marlett J, ... ... Young JA, et al. Global landscape of HIV-human protein complexes. Nature. 481: 365-70. PMID 22190034 DOI: 10.1038/nature10719  1
2011 Pilpa RM, Bayrhuber M, Marlett JM, Riek R, Young JA. A receptor-based switch that regulates anthrax toxin pore formation. Plos Pathogens. 7: e1002354. PMID 22174672 DOI: 10.1371/journal.ppat.1002354  1
2011 Bhattacharyya S, Hope TJ, Young JA. Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology. 419: 1-9. PMID 21855102 DOI: 10.1016/j.virol.2011.07.018  0.01
2011 Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. Journal of Virology. 85: 8359-67. PMID 21632754 DOI: 10.1128/JVI.02582-10  1
2011 Ocwieja KE, Brady TL, Ronen K, Huegel A, Roth SL, Schaller T, James LC, Towers GJ, Young JA, Chanda SK, König R, Malani N, Berry CC, Bushman FD. HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. Plos Pathogens. 7: e1001313. PMID 21423673 DOI: 10.1371/journal.ppat.1001313  1
2011 Jha NK, Latinovic O, Martin E, Novitskiy G, Marin M, Miyauchi K, Naughton J, Young JA, Melikyan GB. Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion. Plos Pathogens. 7: e1001260. PMID 21283788 DOI: 10.1371/journal.ppat.1001260  1
2010 Choi J, Young JA, Callaway EM. Selective viral vector transduction of ErbB4 expressing cortical interneurons in vivo with a viral receptor-ligand bridge protein. Proceedings of the National Academy of Sciences of the United States of America. 107: 16703-8. PMID 20823240 DOI: 10.1073/pnas.1006233107  1
2010 Bruce JW, Hierl M, Young JA, Ahlquist P. Cellular transcription factor ZASC1 regulates murine leukemia virus transcription. Journal of Virology. 84: 7473-83. PMID 20484494 DOI: 10.1128/JVI.00299-10  1
2010 König R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y, Gao Q, Andrews SE, Bandyopadhyay S, De Jesus P, Tu BP, ... ... Young JA, et al. Human host factors required for influenza virus replication. Nature. 463: 813-7. PMID 20027183 DOI: 10.1038/nature08699  1
2009 Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, König R, Bandyopadhyay S, Ideker T, Goff SP, Krogan NJ, Frankel AD, ... Young JA, et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies. Plos Pathogens. 5: e1000437. PMID 19478882 DOI: 10.1371/journal.ppat.1000437  1
2009 Sharma S, Thomas D, Marlett J, Manchester M, Young JA. Efficient neutralization of antibody-resistant forms of anthrax toxin by a soluble receptor decoy inhibitor. Antimicrobial Agents and Chemotherapy. 53: 1210-2. PMID 19075066 DOI: 10.1128/AAC.01294-08  1
2008 Bruce JW, Ahlquist P, Young JA. The host cell sulfonation pathway contributes to retroviral infection at a step coincident with provirus establishment. Plos Pathogens. 4: e1000207. PMID 19008949 DOI: 10.1371/journal.ppat.1000207  1
2008 König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, ... ... Young JA, et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell. 135: 49-60. PMID 18854154 DOI: 10.1016/j.cell.2008.07.032  1
2008 Ryan PL, Young JA. Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. Plos One. 3: e1817. PMID 18350154 DOI: 10.1371/journal.pone.0001817  1
2008 Haldar K, McFadden G, Young JA. Change in the editorial leadership of PLoS Pathogens. Plos Pathogens. 4: e15. PMID 18225955 DOI: 10.1371/journal.ppat.0040015  1
2007 Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJ, Pique ME, Scobie HM, Yeager M, Young JA, Manchester M, Schneemann A. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. Plos Pathogens. 3: 1422-31. PMID 17922572 DOI: 10.1371/journal.ppat.0030142  1
2007 Young J, Haldar K. The impact of PLoS pathogens. Plos Pathogens. 3: 1189-90. PMID 17907807 DOI: 10.1371/journal.ppat.0030145  1
2007 Scobie HM, Marlett JM, Rainey GJ, Lacy DB, Collier RJ, Young JA. Anthrax toxin receptor 2 determinants that dictate the pH threshold of toxin pore formation. Plos One. 2: e329. PMID 17389920 DOI: 10.1371/journal.pone.0000329  1
2007 Young JA, Collier RJ. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annual Review of Biochemistry. 76: 243-65. PMID 17335404 DOI: 10.1146/annurev.biochem.75.103004.142728  1
2007 Wickersham IR, Lyon DC, Barnard RJ, Mori T, Finke S, Conzelmann KK, Young JA, Callaway EM. Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons. Neuron. 53: 639-47. PMID 17329205 DOI: 10.1016/j.neuron.2007.01.033  1
2007 Babel AR, Bruce J, Young JA. The hr1 and fusion peptide regions of the subgroup B avian sarcoma and leukosis virus envelope glycoprotein influence low pH-dependent membrane fusion. Plos One. 2: e171. PMID 17245447 DOI: 10.1371/journal.pone.0000171  1
2006 Scobie HM, Young JA. Divalent metal ion coordination by residue T118 of anthrax toxin receptor 2 is not essential for protective antigen binding. Plos One. 1: e99. PMID 17183731 DOI: 10.1371/journal.pone.0000099  1
2006 Scobie HM, Wigelsworth DJ, Marlett JM, Thomas D, Rainey GJ, Lacy DB, Manchester M, Collier RJ, Young JA. Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. Plos Pathogens. 2: e111. PMID 17054395 DOI: 10.1371/journal.ppat.0020111  1
2006 Keim P, Mock M, Young J, Koehler TM. The International Bacillus anthracis, B. cereus, and B. thuringiensis Conference, "Bacillus-ACT05". Journal of Bacteriology. 188: 3433-41. PMID 16672596 DOI: 10.1128/JB.188.10.3433-3441.2006  1
2005 Bruce JW, Bradley KA, Ahlquist P, Young JA. Isolation of cell lines that show novel, murine leukemia virus-specific blocks to early steps of retroviral replication. Journal of Virology. 79: 12969-78. PMID 16188999 DOI: 10.1128/JVI.79.20.12969-12978.2005  1
2005 Wolfe JT, Krantz BA, Rainey GJ, Young JA, Collier RJ. Whole-cell voltage clamp measurements of anthrax toxin pore current. The Journal of Biological Chemistry. 280: 39417-22. PMID 16183642 DOI: 10.1074/jbc.M509049200  1
2005 Rainey GJ, Wigelsworth DJ, Ryan PL, Scobie HM, Collier RJ, Young JA. Receptor-specific requirements for anthrax toxin delivery into cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 13278-83. PMID 16141341 DOI: 10.1073/pnas.0505865102  1
2005 Scobie HM, Thomas D, Marlett JM, Destito G, Wigelsworth DJ, Collier RJ, Young JA, Manchester M. A soluble receptor decoy protects rats against anthrax lethal toxin challenge. The Journal of Infectious Diseases. 192: 1047-51. PMID 16107958 DOI: 10.1086/432731  1
2005 Klucking S, Collins AS, Young JA. Avian sarcoma and leukosis virus cytopathic effect in the absence of TVB death domain signaling. Journal of Virology. 79: 8243-8. PMID 15956570 DOI: 10.1128/JVI.79.13.8243-8248.2005  1
2005 Melikyan GB, Barnard RJ, Abrahamyan LG, Mothes W, Young JA. Imaging individual retroviral fusion events: from hemifusion to pore formation and growth. Proceedings of the National Academy of Sciences of the United States of America. 102: 8728-33. PMID 15937118 DOI: 10.1073/pnas.0501864102  1
2005 Scobie HM, Young JA. Interactions between anthrax toxin receptors and protective antigen. Current Opinion in Microbiology. 8: 106-12. PMID 15694864 DOI: 10.1016/j.mib.2004.12.005  1
2004 Barnard RJ, Narayan S, Dornadula G, Miller MD, Young JA. Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating. Journal of Virology. 78: 10433-41. PMID 15367609 DOI: 10.1128/JVI.78.19.10433-10441.2004  1
2004 Young JA, Dillin A. MAPping innate immunity. Proceedings of the National Academy of Sciences of the United States of America. 101: 12781-2. PMID 15328410 DOI: 10.1073/pnas.0404890101  1
2004 Lim KI, Narayan S, Young JA, Yin J. Effects of lipid rafts on dynamics of retroviral entry and trafficking: Quantitative analysis. Biotechnology and Bioengineering. 86: 650-60. PMID 15137076 DOI: 10.1002/bit.20108  1
2004 Narayan S, Young JA. Reconstitution of retroviral fusion and uncoating in a cell-free system. Proceedings of the National Academy of Sciences of the United States of America. 101: 7721-6. PMID 15128947 DOI: 10.1073/pnas.0401312101  1
2004 Lacy DB, Wigelsworth DJ, Scobie HM, Young JA, Collier RJ. Crystal structure of the von Willebrand factor A domain of human capillary morphogenesis protein 2: an anthrax toxin receptor. Proceedings of the National Academy of Sciences of the United States of America. 101: 6367-72. PMID 15079089 DOI: 10.1073/pnas.0401506101  1
2003 Collier RJ, Young JA. Anthrax toxin. Annual Review of Cell and Developmental Biology. 19: 45-70. PMID 14570563 DOI: 10.1146/annurev.cellbio.19.111301.140655  1
2003 Bradley KA, Mogridge J, Jonah G, Rainey A, Batty S, Young JA. Binding of anthrax toxin to its receptor is similar to alpha integrin-ligand interactions. The Journal of Biological Chemistry. 278: 49342-7. PMID 14507921 DOI: 10.1074/jbc.M307900200  1
2003 Yu X, Wang QY, Guo Y, Dolmer K, Young JA, Gettins PG, Rong L. Kinetic analysis of binding interaction between the subgroup A Rous sarcoma virus glycoprotein SU and its cognate receptor Tva: calcium is not required for ligand binding. Journal of Virology. 77: 7517-26. PMID 12805452 DOI: 10.1128/JVI.77.13.7517-7526.2003  1
2003 Scobie HM, Rainey GJ, Bradley KA, Young JA. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proceedings of the National Academy of Sciences of the United States of America. 100: 5170-4. PMID 12700348 DOI: 10.1073/pnas.0431098100  1
2003 Bradley KA, Young JA. Anthrax toxin receptor proteins. Biochemical Pharmacology. 65: 309-14. PMID 12527323 DOI: 10.1016/S0006-2952(02)01455-7  1
2003 Narayan S, Barnard RJ, Young JA. Two retroviral entry pathways distinguished by lipid raft association of the viral receptor and differences in viral infectivity. Journal of Virology. 77: 1977-83. PMID 12525631 DOI: 10.1128/JVI.77.3.1977-1983.2003  1
2002 Klucking S, Adkins HB, Young JA. Resistance to infection by subgroups B, D, and E avian sarcoma and leukosis viruses is explained by a premature stop codon within a resistance allele of the tvb receptor gene. Journal of Virology. 76: 7918-21. PMID 12097608 DOI: 10.1128/JVI.76.15.7918-7921.2002  1
2002 Chi Y, Diaz-Griffero F, Wang C, Young JA, Brojatsch J. An NF-kappa B-dependent survival pathway protects against cell death induced by TVB receptors for avian leukosis viruses. Journal of Virology. 76: 5581-7. PMID 11991986 DOI: 10.1128/JVI.76.11.5581-5587.2002  1
2002 Knauss DJ, Young JA. A fifteen-amino-acid TVB peptide serves as a minimal soluble receptor for subgroup B avian leukosis and sarcoma viruses. Journal of Virology. 76: 5404-10. PMID 11991969 DOI: 10.1128/JVI.76.11.5404-5410.2002  1
2002 Snitkovsky S, Young JA. Targeting retroviral vector infection to cells that express heregulin receptors using a TVA-heregulin bridge protein. Virology. 292: 150-5. PMID 11878917 DOI: 10.1006/viro.2001.1314  1
2002 Young JA, Collier JR. Attacking anthrax. Scientific American. 286: 48-50, 54-9. PMID 11857900  1
2001 Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA. Identification of the cellular receptor for anthrax toxin. Nature. 414: 225-9. PMID 11700562 DOI: 10.1038/n35101999  1
2001 Adkins HB, Blacklow SC, Young JA. Two functionally distinct forms of a retroviral receptor explain the nonreciprocal receptor interference among subgroups B, D, and E avian leukosis viruses. Journal of Virology. 75: 3520-6. PMID 11264341 DOI: 10.1128/JVI.75.8.3520-3526.2001  1
2001 Snitkovsky S, Niederman TM, Mulligan RC, Young JA. Targeting avian leukosis virus subgroup A vectors by using a TVA-VEGF bridge protein. Journal of Virology. 75: 1571-5. PMID 11152532 DOI: 10.1128/JVI.75.3.1571-1575.2001  1
2000 Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell. 103: 679-89. PMID 11106737  1
2000 Brojatsch J, Naughton J, Adkins HB, Young JA. TVB receptors for cytopathic and noncytopathic subgroups of avian leukosis viruses are functional death receptors. Journal of Virology. 74: 11490-4. PMID 11090145 DOI: 10.1128/JVI.74.24.11490-11494.2000  1
2000 Snitkovsky S, Niederman TM, Carter BS, Mulligan RC, Young JA. A TVA-single-chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. Journal of Virology. 74: 9540-5. PMID 11000224 DOI: 10.1128/JVI.74.20.9540-9545.2000  1
2000 Adkins HB, Brojatsch J, Young JA. Identification and characterization of a shared TNFR-related receptor for subgroup B, D, and E avian leukosis viruses reveal cysteine residues required specifically for subgroup E viral entry. Journal of Virology. 74: 3572-78. PMID 10729132 DOI: 10.1128/JVI.74.8.3572-3578.2000  1
1999 Boerger AL, Snitkovsky S, Young JA. Retroviral vectors preloaded with a viral receptor-ligand bridge protein are targeted to specific cell types. Proceedings of the National Academy of Sciences of the United States of America. 96: 9867-72. PMID 10449786 DOI: 10.1073/pnas.96.17.9867  1
1998 Snitkovsky S, Young JA. Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein. Proceedings of the National Academy of Sciences of the United States of America. 95: 7063-8. PMID 9618539 DOI: 10.1073/pnas.95.12.7063  1
1998 Bates P, Rong L, Varmus HE, Young JA, Crittenden LB. Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus. Journal of Virology. 72: 2505-8. PMID 9499114  1
1997 Adkins HB, Brojatsch J, Naughton J, Rolls MM, Pesola JM, Young JA. Identification of a cellular receptor for subgroup E avian leukosis virus. Proceedings of the National Academy of Sciences of the United States of America. 94: 11617-22. PMID 9326659 DOI: 10.1073/pnas.94.21.11617  1
1994 Federspiel MJ, Bates P, Young JA, Varmus HE, Hughes SH. A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proceedings of the National Academy of Sciences of the United States of America. 91: 11241-5. PMID 7972042 DOI: 10.1073/pnas.91.23.11241  1
1993 Bates P, Young JA, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell. 74: 1043-51. PMID 8402880 DOI: 10.1016/0092-8674(93)90726-7  1
1993 Young JA, Bates P, Varmus HE. Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. Journal of Virology. 67: 1811-6. PMID 8383211  1
1990 Young JA, Bates P, Willert K, Varmus HE. Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science (New York, N.Y.). 250: 1421-3. PMID 2175047  1
1987 Bodmer J, Bodmer W, Heyes J, So A, Tonks S, Trowsdale J, Young J. Identification of HLA-DP polymorphism with DP alpha and DP beta probes and monoclonal antibodies: correlation with primed lymphocyte typing. Proceedings of the National Academy of Sciences of the United States of America. 84: 4596-600. PMID 2885841  1
Show low-probability matches.